July 22, 2020
Alison Buttenheim Appointed to National Committee on the Equitable Allocation of COVID-19 Vaccines
Associate Professor of Health Policy Alison Buttenheim, PhD, MBA, has been appointed to an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine (NASEM) and National Academy of Medicine to provide a framework for the equitable allocation of vaccines for the novel coronavirus.
This committee will work together to develop guidance for policymakers in the domestic and global health communities when a COVID-19 vaccine has been created.
Some of the questions the committee members will consider, according to the NASEM website, include:
- “What criteria should be used in setting priorities for equitable allocation of vaccine?
- How should the criteria be applied in determining the first tier of vaccine recipients? As more vaccine becomes available, what populations should be added successively to the priority list of recipients?
- If multiple vaccine candidates are available, how should we ensure equity?
- How can countries ensure equity in allocation of COVID-19 vaccines?
- For the US, how can communities of color be assured access to vaccination?”
“Equitable access to a future vaccine is such a critical issue,” Dr. Buttenheim said. “I am deeply honored to join the NASEM committee at this moment in the pandemic, and hope I can contribute expertise and a unique voice to our work.”